Noticeably, cells expressing high levels of Nm23‐H1 exhibit a pronounced KSR1 degradation [52], suggestive of a correlation between KSR1 levels and an adverse evolution of mammary cancer patients, as our findings related to clinical data demonstrate. Here, NME1 is linked to breast cancer.